Today: 24 January 2026
Subscribe
Browse Category

NYSE:GILD News 23 January 2026

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

New York, Jan 23, 2026, 15:38 EST — Regular session Gilead Sciences shares climbed $4.59, or 3.5%, to $135.73 in Friday afternoon trading, building on a strong two-day surge and hitting new highs. The stock started the day at $131.26 and fluctuated between $130.65 and $136.26, with roughly 8.8 million shares traded. This week, Gilead updated investors after The New…
23 January 2026
·······

Stock Market Today

  • Indraprastha Medical Corporation Sees 10% Stock Drop Amid High Individual Investor Stakes
    January 23, 2026, 11:17 PM EST. Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) experienced a 10% decline in stock price last week, falling to a market cap of ₹33 billion. Individual investors hold 40% of the company, making them the most impacted by this downturn. The top three shareholders, including India as the largest with 26% ownership, collectively control over 51% of shares, influencing key company decisions. Institutional investors maintain a notable but smaller stake, signaling some analyst support. However, the absence of significant hedge fund interest and recent price volatility raise concerns for all shareholders. The stock's past earnings trajectory and ownership structure highlight potential risks and power dynamics within the firm's governance.
Go toTop